Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus

Nucleic Acids Research

Volumn 30, Issue 21, 2002, Pages 4682-4691

  Bergeron, Lecien Junior ^a   Perreault, Jean Pierre ^a  

^a Groupe en Sciences des Radiations   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; OLIGONUCLEOTIDE; RIBONUCLEASE; RIBOZYME; VIRUS RNA;

ARTICLE; BIOINFORMATICS; COMBINATORIAL LIBRARY; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME SUBSTRATE COMPLEX; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HYDROLYSIS; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME;

DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; RNA VIRUSES;

EID: 0036849469     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkf598     Document Type: Article

References (38)

1. Lewin, A.S. and Hauswirth, W.W. (2001) Ribozyme gene therapy: application for molecular medicine. Trends Mol. Med., 7, 221-228.
2. Michienzi, A. and Rossi, J.J. (2001) Intracellular applications of ribozymes. Methods Enzymol., 341, 581-596.
3. Sun, L.Q., Cairns, M.J., Saravolac, E.G., Baker, A. and Gerlach, W.L. (2000) Catalytic nucleic acids: from lab to application. Pharmacol. Rev., 52, 325-347.
4. Shih, I.H. and Been, M.D. (2002) Catalytic strategies of the hepatitis delta virus ribozymes. Annu. Rev. Biochem., 71, 887-917.
5. Lévesque, D., Choufani, S. and Perreault, J.P. (2002) Delta ribozyme benefits from a good stability in vitro that becomes outstanding in vivo. RNA, 8, 464-477.
6. Ananvoranich, S. and Perreault, J.P. (1998) Substrate specificity of δ ribozyme cleavage. J. Biol. Chem., 273, 13182-13188.
7. Mercure, S., Lafontaine, D., Ananvoranich, S. and Perreault, J.P. (1998) Kinetic analysis of δ ribozyme cleavage. Biochemistry, 37, 16975-16982.
8. Campbell, T.B. and Cech, T.R. (1995) Identification of ribozymes within a ribozyme library that efficiently cleave a long substrate RNA. RNA, 1, 598-609.
9. Birikh, K.R., Berlin, Y.A., Soreq, H. and Eckstein, F. (1997) Probing accessible sites for ribozymes on human acetylcholinesterase RNA. RNA, 3, 429-437.
10. Roy, G., Ananvoranich, S. and Perreault, J.P. (1999) Delta ribozyme has the ability to cleave in trans an mRNA. Nucleic Acids Res., 27, 942-948.
11. Lima W.F., Brown-Driver, V., Fox, M., Hanecak, R. and Bruice, T.W. (1997) Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. J. Biol. Chem., 272, 626-638.
12. Yu, Q., Pecchia, D.B., Kingsley, S.L., Heckman, J.E. and Burke J.M. (1998) Cleavage of highly structured viral RNA molecules by combinatorial libraries of hairpin ribozymes. J. Biol. Chem., 273, 23524-23533.
13. Mathews, D.H., Burkard, M.E., Freier, S.M., Wyatt, J.R. and Turner, D.H. (1999) Predicting oligonucleotide affinity to nucleic targets. RNA, 5, 1458-1469.
14. zu Putlitz, J., Yu, Q., Burke J.M. and Wands, J.R. (1999) Combinatorial screening and intracellular antiviral activity of hairpin ribozymes directed against hepatitis B virus. J. Virol., 73, 5381-5387.
15. Scherr, M., Rossi J.J., Sczakiel, G. and Patzel, V. (2000) RNA accessibility prediction: a theoritical approach is consistent with experimental studies in cell extracts. Nucleic Acids Res., 28, 2455-2461.
16. Amarzguioui, M., Brede, G., Babaie, E., Grotli, M., Sproat, B. and Prydz, H. (2000) Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes. Nucleic Acids Res., 28, 4113-4124.
17. Scherr, M., LeBon J., Castanotto, D., Cunliffe, H.E., Meltzer, P.S., Ganser, A., Riggs, A.D. and Rossi J.J. (2001) Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA. Mol. Ther., 4, 454-460.
18. Barroso-delJesus, A. and Berzal-Herranz, A. (2001) Selection of targets and the most efficient hairpin ribozymes for inactivation of mRNAs using a self-cleaving RNA library. EMBO Rep., 21, 1112-1118.
19. Krüger, M., Beger, C., Welch, P.J., Berber, J.R. and Wong-Staal, F. (2001) C-SPACE (cleavage-specific amplification of cDNA ends): a novel method of ribozyme-mediated gene identification. Nucleic Acids Res., 29, e94.
20. Sohail, M., Hochegger, H., Klotzbücher, A., Le Guellec, R., Hunt, T. and Southern, E.M. (2001) Antisense oligonucleotides selected by hybridization to scanning arrays are effective reagents in vivo. Nucleic Acids Res., 29, 2041-2051.
21. Pan, W.H., Devlin, H.F., Kelley, C., Isom, H.C. and Clawson, G.A. (2001) A selection system for identifying accessible sites in target RNAs. RNA, 7, 610-621.
22. Ding, Y. and Lawrence, C.E. (2001) Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond. Nucleic Acids Res., 29, 1034-1046.
23. Tong, C.Y.W. (2000) Genetic variations of hepatitis B virus. Curr. Opin. Infect. Dis., 13, 481-487.
24. Welch, P.J., Tritz, R., Yei, S., Barber J. and Yu, M. (1997) Intracellular application of hairpin ribozyme genes against hepatitis B virus. Gene Ther., 4, 736-743.
25. Weinberg, M., Passman, M., Kew, M. and Arbuthnot, P. (2000) Hammerhead ribozyme-mediated inhibition of hepatitis B virus X gene expression in cultured cells. J. Hepatol., 33, 142-151.
26. Nassal, M. (1992) The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and production viral positive-strand DNA synthesis but not for virus assembly. J. Virol., 66, 4107-4116.
27. Mathews, D.H., Sabina J., Zuker, M. and Turner, D.H. (1999) Expanded sequence dependence of thermodynamic parameters provides improved prediction of RNA secondary structures. J. Mol. Biol., 288, 911-940.
28. Thompson, J.D., Higgins, D.G. and Gibson, T.J. (1994) Clustal W-improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res., 22, 4673-4680.
29. Nishikawa, F., Fauzi, H. and Nishikawa, S. (1997) Detailed analysis of base preferences at the cleavage site of a trans-acting HDV ribozyme: a mutation that changes cleavage site specificity. Nucleic Acids Res., 27, 403-410.
30. Deschênes, P., Lafontaine, D.A., Charland, S. and Perreault, J.P. (2000) Nucleotides -1 to -4 of hepatitis delta ribozyme substrate increase the specificity of ribozyme cleavage. Antisense Nucleic Acid Drug Dev., 10, 53-61.
31. Ananvoranich, S., Lafontaine, D.A. and Perreault, J.P. (1999) Mutational analysis of the antigenomic trans-acting delta ribozyme: the alterations of the middle nucleotides located on the P1 stem. Nucleic Acids Res., 17, 1473-1479.
32. Hogrefe, H.H., Hogrefe, R.I., Walder, R.Y. and Walder J.A. (1990) Kinetic analysis of Escherichia coli RNase H using DNA-RNA-DNA/DNA substrates. J. Biol. Chem., 265, 5561-5566.
33. Shih, I.H. and Been, M.D. (2001) Energetic contribution of non-essential 5′ sequence to catalysis in a hepatitis delta virus ribozyme. EMBO J., 20, 4884-4891.
34. Feng, Y., Kong, Y.Y., Wang, Y. and Qi, G. (2001) Inhibition of hepatitis B virus by hammerhead ribozyme targeted to the poly(A) signal sequence in cultured cells. Biol. Chem., 382, 655-660.
35. Beck J. and Nassal, M. (1995) Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells. Nucleic Acids Res., 23, 4954-4962.
36. Kim, Y.K., Junn, E., Park, I., Lee, Y., Kang, C. and Ahn, J.K. (1999) Repression of hepatitis B virus X gene expression by hammerhead ribozymes. Biochem. Biophys. Res. Commun., 257, 759-765.
37. Passman, M., Weinberg, M., Kew, M. and Arbuthnot, P. (2000) In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells. Biochem. Biophys. Res. Commun., 268, 728-733.
38. Kato, Y., Kuwabara, T., Warashina, M., Toda, H. and Taira, K. (2001) Relationships between the activities in vitro and in vivo of various kinds of ribozyme and their intracellular localization in mammalian cells. J. Biol. Chem., 276, 15378-15385.